RAMOT AT TEL-AVIV UNIVERSITY LTD.;THOMAS JEFFERSON UNIVERSITY
发明人:
Nir Ben-Tal,Roger S. Armen,Laurence C. Eisenlohr,Jitendra Belani,Michael Miller,Inbar Fish,Ori Kalid
申请号：
US16062253
公开号：
US20180370910A1
申请日:
2016.12.19
申请国别(地区):
US
年份:
2018
代理人:
摘要：
An effective therapeutic agent for the M2 channel comprising sulfonylamide or oxabicyclo structures effective for treating amantadine-resistant influenza A infections, and methods of treating amantadine-resistant influenza A infections through administration of the same.
